Inside Immunai: Can artificial intelligence map our immune system?

Failed to add items

Sorry, we are unable to add the item because your shopping basket is already at capacity.

Add to cart failed.

Please try again later

Add to wishlist failed.

Please try again later

Remove from wishlist failed.

Please try again later

Follow podcast failed

Unfollow podcast failed

Inside Immunai: Can artificial intelligence map our immune system?

Listen for free

View show details

About this listen

This week, host Eve Young, economics correspondent for The Jerusalem Post, interviews Noam Solomon - CEO and co-founder at Immunai.

Immunai is a biotechnology company working to comprehensively map and decode the immune system with single-cell biology and AI to make new therapeutic discoveries, accelerate drug development, and improve patient outcomes.

Noam will talk about how Immunai uses AI and machine learning to make medical advancements, and explain what machine learning is in laymans terms. He will also explain what kind of team is best suited to face the challenges of a complex, deep science problem like mapping human immunity.

No reviews yet